Berberine: a potential phytochemical with multispectrum therapeutic activities

被引:265
作者
Vuddanda, Parameswara Rao [1 ]
Chakraborty, Subhashis [1 ]
Singh, Sanjay [1 ]
机构
[1] Banaras Hindu Univ, Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India
关键词
berberine; lipids; multidrug resistance; P-gp; P-gp inhibitors; polymers; ENHANCED ORAL BIOAVAILABILITY; GLYCOPROTEIN MEDIATED EFFLUX; P-GLYCOPROTEIN; IN-VITRO; INTESTINAL-ABSORPTION; DRUG TRANSPORTERS; NATURAL-PRODUCT; FUNCTIONAL-ROLE; UP-REGULATION; MECHANISM;
D O I
10.1517/13543784.2010.517745
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Importance of the field: The use of traditional medicines of natural origin is being encouraged for the treatment of chronic disorders, as synthetic drugs in such cases may cause unpredictable adverse effects. Berberine, a traditional plant alkaloid, is used in Ayurvedic and Chinese medicine for its antimicrobial and antiprotozoal properties. Interestingly, current clinical research on berberine has revealed its various pharmacological properties and multi-spectrum therapeutic applications. Areas covered in this review: An extensive search in three electronic data-bases (Unbound Medline, PubMed and ScienceDirect) and internet search engines (Scirus and Google Scholar) were used to identify the clinical studies on berberine, without any time constraints. This review elaborates the recent studies which reveal that with time, the drug has evolved with superior therapeutic activities. In addition, this review will also attract the attention of formulation scientists towards the issues and challenges associated in its drug delivery and the probable approaches that may be explored to help patients reap the maximum benefit of this potentially useful drug. What the reader will gain: A relatively large number of studies discussed here have revealed the possible areas where this phytochemical constituent can exhibit its therapeutic activities in the treatment of chronic ailments or diseases including diabetes, cancer, depression, hypertension and hypercholesterolemia. Take home message: The potential of the drug remains to be harvested by designing a suitable formulation that could overcome its inherent low bioavailability.
引用
收藏
页码:1297 / 1307
页数:11
相关论文
共 76 条
[1]   Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [J].
Abidi, P ;
Zhou, Y ;
Jiang, JD ;
Liu, JW .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2170-2176
[2]   The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1) [J].
Ambudkar, SV ;
Kim, IW ;
Sauna, ZE .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (05) :392-400
[3]  
Arayne MS, 2007, PAK J PHARM SCI, V20, P83
[4]   Role of transport proteins in drug absorption, distribution and excretion [J].
Ayrton, A ;
Morgan, P .
XENOBIOTICA, 2001, 31 (8-9) :469-497
[5]   Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation [J].
Bansal, Tripta ;
Akhtar, Naseem ;
Jaggi, Manu ;
Khar, Roop K. ;
Talegaonkar, Sushama .
DRUG DISCOVERY TODAY, 2009, 14 (21-22) :1067-1074
[6]   Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy [J].
Bansal, Tripta ;
Jaggi, Manu ;
Khar, Roop K. ;
Talegaonkar, Sushama .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2009, 12 (01) :46-78
[7]   Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers [J].
Batrakova, Elena V. ;
Kabanov, Alexander V. .
JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) :98-106
[8]  
BENSKY D., 1993, CHINESE HERBAL MED M
[9]  
Bernkop-Schnurch A., 2006, Am. J. Drug Deliv., V4, P263, DOI [10.2165/00137696-200604040-00008, DOI 10.2165/00137696-200604040-00008]
[10]  
Bin C, 1987, J TONGJI MED U, V7, P239